Please login to the form below

Not currently logged in
Email:
Password:

free-spending

This page shows the latest free-spending news and features for those working in and with pharma, biotech and healthcare.

A frugal future

A frugal future

more. But that environment is changing. Free-spending, arguably profligate life science companies will die out and frugal, ruthlessly efficient companies will replace them. ... Free-spending, arguably profligate life science companies will die out and

Latest news

  • Life sciences minister: Go digital for NHS savings Life sciences minister: Go digital for NHS savings

    Greater use of health technology could free funds for drug spending, says George Freeman.

  • GSK accused of intimidation

    GSK also lobbied on the Medicare prescription drug programme, legislation which proposes an expansion of child healthcare, government spending on health programmes and several free trade agreements, according to the form

  • News in brief, April 25, 2007

    The 33 countries also included three candidate countries: Croatia, Macedonia, Turkey and the European Free Trade Area (EFTA) nations Iceland, Norway and Switzerland. ... Pharmaceutical firms say that if the legislation went ahead, it would impact their

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...